Abbvie reported $14.81B in Sales Revenues for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Abbott ABT:US USD 10.41B 847M
Abbvie ABBV:US USD 14.81B 229M
Amgen AMGN:US USD 6.65B 58M
AstraZeneca AZN:LN USD 10.98B 211M
Astrazeneca AZN:US USD 10.98B 211M
Biogen BIIB:US USD 2.51B 80.6M
Biomarin Pharmaceutical BMRN:US USD 505.34M 28.45M
Bristol Myers Squibb BMY:US USD 11.22B 669M
Coherus Biosciences CHRS:US USD 45.42M 14.73M
Eisai 4523:JP JPY 174.36B 9.9B
Eli Lilly And LLY:US USD 6.94B 453.6M
Endo International Ordinary Shares ENDP:US USD 541.69M 27.42M
Gilead Sciences GILD:US USD 7.04B 782M
GlaxoSmithKline GSK:LN GBP 782.9B 90B
Horizon Pharma HZNP:US USD 925.36M 48.95M
Infinity Pharmaceuticals INFI:US USD 712K 26K
Intercept Pharmaceuticals ICPT:US USD 77.59M 5.83M
Johnson & Johnson JNJ:US USD 23.79B 229M
Medtronic MDT:US USD 7.59B 214M
Merk MRK:US USD 14.96B 366M
Neurocrine Biosciences NBIX:US USD 387.9M 9.7M
Novartis NOVN:VX USD 12.84B 243M
Pacira Pharmaceuticals PCRX:US USD 167.47M 1.94M
Perrigo Ordinary Shares PRGO:US USD 1.1B 21.5M
Pfizer PFE:US USD 22.64B 5.1B
Regeneron Pharmaceuticals REGN:US USD 2.94B 79M
Revance Therapeutics RVNC:US USD 29.01M 647K
Roche Holding ROG:VX CHF 32.3B 207M
Teva Pharmaceutical Industries TEVA:US USD 3.6B 191M
Ultragenyx Pharmaceutical RARE:US USD 90.7M 1.36M
United Therapeutics UTHR:US USD 516M 49.1M
Vertex Pharmaceuticals VRTX:US USD 2.33B 138.1M
Zoetis ZTS:US USD 2B 50M